These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25404465)

  • 1. PARP inhibitor, olaparib ameliorates acute lung and kidney injury upon intratracheal administration of LPS in mice.
    Kapoor K; Singla E; Sahu B; Naura AS
    Mol Cell Biochem; 2015 Feb; 400(1-2):153-62. PubMed ID: 25404465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological inhibition of poly (ADP-ribose) polymerase by olaparib, prevents acute lung injury associated cognitive deficits potentially through suppression of inflammatory response.
    Sahu B; Narota A; Naura AS
    Eur J Pharmacol; 2020 Jun; 877():173091. PubMed ID: 32234526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PARP-1 inhibition ameliorates elastase induced lung inflammation and emphysema in mice.
    Dharwal V; Naura AS
    Biochem Pharmacol; 2018 Apr; 150():24-34. PubMed ID: 29355504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological inhibition of poly (ADP-ribose) polymerase by olaparib ameliorates influenza-virus-induced pneumonia in mice.
    Liu W; Ren X; Wang Q; Zhang Y; Du J
    Eur J Clin Microbiol Infect Dis; 2021 Jan; 40(1):159-167. PubMed ID: 32865668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARP is activated in human asthma and its inhibition by olaparib blocks house dust mite-induced disease in mice.
    Ghonim MA; Pyakurel K; Ibba SV; Wang J; Rodriguez P; Al-Khami AA; Lammi MR; Kim H; Zea AH; Davis C; Okpechi S; Wyczechowska D; Al-Ghareeb K; Mansy MS; Ochoa A; Naura AS; Boulares AH
    Clin Sci (Lond); 2015 Dec; 129(11):951-62. PubMed ID: 26205779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of poly (adenosine diphosphate-ribose) polymerase attenuates lung-kidney crosstalk induced by intratracheal lipopolysaccharide instillation in rats.
    Si MK; Mitaka C; Tulafu M; Abe S; Kitagawa M; Ikeda S; Eishi Y; Kurata S; Tomita M
    Respir Res; 2013 Nov; 14(1):126. PubMed ID: 24229378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trials.
    Yuan B; Ye N; Song SS; Wang YT; Song Z; Chen HD; Chen CH; Huan XJ; Wang YQ; Su Y; Shen YY; Sun YM; Yang XY; Chen Y; Guo SY; Gan Y; Gao ZW; Chen XY; Ding J; He JX; Zhang A; Miao ZH
    Cancer Lett; 2017 Feb; 386():47-56. PubMed ID: 27847302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARP inhibition by olaparib alleviates chronic asthma-associated remodeling features via modulating inflammasome signaling in mice.
    Sethi GS; Sharma S; Naura AS
    IUBMB Life; 2019 Jul; 71(7):1003-1013. PubMed ID: 30964965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.
    Min A; Im SA; Kim DK; Song SH; Kim HJ; Lee KH; Kim TY; Han SW; Oh DY; Kim TY; O'Connor MJ; Bang YJ
    Breast Cancer Res; 2015 Mar; 17():33. PubMed ID: 25888415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARP-1 inhibitor, DPQ, attenuates LPS-induced acute lung injury through inhibiting NF-κB-mediated inflammatory response.
    Wang G; Huang X; Li Y; Guo K; Ning P; Zhang Y
    PLoS One; 2013; 8(11):e79757. PubMed ID: 24278171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
    Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
    J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARP-1 inhibition provides protection against elastase-induced emphysema by mitigating the expression of matrix metalloproteinases.
    Dharwal V; Sandhir R; Naura AS
    Mol Cell Biochem; 2019 Jul; 457(1-2):41-49. PubMed ID: 30993494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinically used PARP inhibitor olaparib improves organ function, suppresses inflammatory responses and accelerates wound healing in a murine model of third-degree burn injury.
    Ahmad A; Olah G; Herndon DN; Szabo C
    Br J Pharmacol; 2018 Jan; 175(2):232-245. PubMed ID: 28146604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PolyADP-Ribosylation of NFATc3 and NF-κB Transcription Factors Modulate Macrophage Inflammatory Gene Expression in LPS-Induced Acute Lung Injury.
    Nie Y; Nirujogi TS; Ranjan R; Reader BF; Chung S; Ballinger MN; Englert JA; Christman JW; Karpurapu M
    J Innate Immun; 2021; 13(2):83-93. PubMed ID: 33045713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition.
    Yang S; Yu Z; Wang L; Yuan T; Wang X; Zhang X; Wang J; Lv Y; Du G
    J Ethnopharmacol; 2017 Mar; 200():147-155. PubMed ID: 28192201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olaparib: an oral PARP-1 and PARP-2 inhibitor with promising activity in ovarian cancer.
    Gunderson CC; Moore KN
    Future Oncol; 2015; 11(5):747-57. PubMed ID: 25757679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of magnolol on the Toll-like receptor 4/nuclear factor κB signaling pathway in lipopolysaccharide-induced acute lung injury in mice.
    Yunhe F; Bo L; Xiaosheng F; Fengyang L; Dejie L; Zhicheng L; Depeng L; Yongguo C; Xichen Z; Naisheng Z; Zhengtao Y
    Eur J Pharmacol; 2012 Aug; 689(1-3):255-61. PubMed ID: 22683864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of poly(ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation.
    Liaudet L; Pacher P; Mabley JG; Virág L; Soriano FG; Haskó G; Szabó C
    Am J Respir Crit Care Med; 2002 Feb; 165(3):372-7. PubMed ID: 11818323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK/NF-κB pathway.
    Li W; Qiu X; Jiang H; Zhi Y; Fu J; Liu J
    Int Immunopharmacol; 2015 Dec; 29(2):560-567. PubMed ID: 26481965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tempol, a membrane-permeable radical scavenger, ameliorates lipopolysaccharide-induced acute lung injury in mice: a key role for superoxide anion.
    El-Sayed NS; Mahran LG; Khattab MM
    Eur J Pharmacol; 2011 Aug; 663(1-3):68-73. PubMed ID: 21554869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.